General Information of the Compound
Compound ID |
CP0014598
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
AMANTADINE
Show/Hide
|
||||||||||||||||||
Synonyms |
1-Adamantamine
1-Adamantanamine
1-Adamantanamine (8CI)
1-Adamantylamine
1-Aminoadamantane
1-Aminotricyclo(3.3.1.1(sup 3,7))decane
1-adamantaneamine
768-94-5
ADAMANTANE,1-AMINO
Adamantamine
Adamantan-1-amine
Adamantan-1-ylamine
Adamantanamine
Adamantylamine
Amant
Amantadina
Amantadina [INN-Spanish]
Amantadine
Amantadine (INN)
Amantadine Base
Amantadine [INN:BAN]
Amantadinum
Amantadinum [INN-Latin]
Amantidine
Aminoadamantane
BIA4304
Endantadine
Gen-Amantadine
Gocovri
HSDB 3202
Mantadine
NSC 341865
OR14310
Pk-merz
Symadine
Symmetrel
Symmetrel (TN)
TCMDC-125869
Tricyclo(3.3.1.1(3,7))-decan-1-amine
Tricyclo(3.3.1.1(sup 3,7))decan-1-amine
Tricyclo(3.3.1.1(sup 3.7))decan-1-amine
Tricyclo(3.3.1.13,7)decan-1-amine
Tricyclo[3Tricyclo[3.3.1.1(3,7)]decan-1-amine
Tricyclo[3.3.1.1(3,7)]decan-1-ylamine
Tricyclo[3.3.1.1(3,7)]decane-1-amine
Tricyclo[3.3.1.1(sup3,7)]decan-1-amine
Tricyclo[3.3.1.1^3,7]decan-1-amine
Tricyclo[3.3.1.1~3,7~]decan-1-amine
UNII-BF4C9Z1J53
Wiregyt
adamantan-1-amine
adamantan-1-ylamine
tricyclo[3.3.1.1~3,7~]decan-1-amine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H17N
|
||||||||||||||||||
Molecular Weight |
151.253
|
||||||||||||||||||
Canonical SMILES |
NC12CC3CC(CC(C3)C1)C2
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2
Show/Hide
|
||||||||||||||||||
InChIKey |
DKNWSYNQZKUICI-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
768-94-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Amantadine )
Drug Name | Amantadine | ||
---|---|---|---|
Indication | |||
Target(s) |
Influenza M2 protein (Influ M)
Inhibitor
|